Clinical Trials
Source: Solr
- Score: 1Liver
A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)
- Ages18 years and older
- GenderBoth
- Score: 1Pancreatic Cancer
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs
- Score: 1Endocrine System
Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
- Ages18 years - 80 years
- GenderBoth
- Score: 1Digestive System
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Score: 1Immune System
Inhibition of Sterile Inflammation by Digoxin
- Ages18 years - 70 years
- GenderBoth
- Score: 1Liver
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) (MIRNA)
- Ages18 years - 75 years
- GenderBoth
- Score: 1Liver
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
- Ages18 years - 75 years
- GenderBoth
- Score: 1Hepatitis, HIV/AIDS, Immune System, Infectious Disease
Screening In Anticipation of Future Research
- Ages2 years - 17 years
- GenderBoth
- Score: 1Immune System
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
- Ages18 years - 75 years
- GenderBoth
- Score: 1Pancreatic Cancer
The Cancer of the Pancreas Screening-5 (CAPS5) Study
- Ages18 years and older
- GenderBoth